Yavuzalp Solak

Dr. Yavuzalp Solak

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
KKKuntay Kaplan
Kuntay Kaplan
YSYavuzalp Solak
Yavuzalp Solak
Kaplan K, et al. J Korean Med Sci. 2023 Feb;38(7):e50. https://doi.org/10.3346/jkms.2023.38.e50

15 February 2020 in Journal of Public Health
Verified
Journal Article
Closed access
PDF file
YSYavuzalp Solak
Yavuzalp Solak
BYBanu Elcin Yoldascan
Banu Elcin Yoldascan
RORamazan Azim Okyay
Ramazan Azim Okyay

12 December 2022 in Hypertension Research
Verified
Journal Article
Closed access
PDF file
EKErhan Kaya
Erhan Kaya
YSYavuzalp Solak
Yavuzalp Solak
MSMUSA SAHIN
MUSA SAHIN
BKBurak Kurt
Burak Kurt
GSGurgun Tuğçe Vural Solak
Gurgun Tuğçe Vural Solak
HÜHüseyin ÜÇER
Hüseyin ÜÇER

1 January 2023 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
MGMuhammed Semih Gedik
Muhammed Semih Gedik
AKAli İhSan Kilci
Ali İhSan Kilci
HHHakan Hakkoymaz
Hakan Hakkoymaz
ÖKÖmer Faruk Küçük
Ömer Faruk Küçük
YSYavuzalp Solak
Yavuzalp Solak
YÇYunus Emre Çıkrıkçı
Yunus Emre Çıkrıkçı
OBJECTIVE: Postvaccine side effects were evaluated in patients presenting to our emergency department with complaints of vaccine side effects after taking COVID-19 vaccine, and new unknown side effects ranging from mild complaints to life-threatening risks, and frequency of all side effects were investigated. This study aimed to establish a scientific resource to identify the potential side effects of the vaccine.METHODS: Patients' demographic information, clinical characteristics, epicrisis reports, COVID-19 disease and vaccination histories, vital values, and blood values were examined. The SPSS 20.0 package program was used for statistical evaluation. p<0.05 was considered statistically significant.RESULTS: Notably, 13.1% of patients presenting to the emergency department started to have complaints after taking Sinovac vaccine, whereas 86.9% of them had complaints after taking BioNTech vaccine. Also, 36.9% of patients stated that they had COVID-19. All patients had a Glasgow coma scale score of 15 during admission. No patient was hospitalized, ventilator was not needed, and all patients were discharged. While the most common presenting complaint to the emergency department after vaccination was fatigue in 29.7%, the most common diagnoses after examination in the emergency department were myalgia in 32.1% and upper respiratory tract infection in 28.6%.CONCLUSION: Results and conclusions of our study will guide healthcare workers and patients on the side effects of COVID-19 vaccine.

1 January 2023 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
HHHakan Hakkoymaz
Hakan Hakkoymaz
MGMuhammed Semih Gedik
Muhammed Semih Gedik
AKAli İhsan Kilci
Ali İhsan Kilci
RORamazan Azim Azim Okyay
Ramazan Azim Azim Okyay
YSYavuzalp Solak
Yavuzalp Solak
In our study, it was aimed to compare the power of trauma scores (Glasgow Coma Score, Revised Trauma Score, Abbreviated Injury Scale, Injury Severity Score, and Trauma Score-Injury Severity Score) in order to predict mortality in patients with geriatric trauma and to determine the predictive values of these scores in mortality.

28 March 2023 in Turkish Journal of Child and Adolescent Mental Health
Verified
Journal Article
Closed access
YSYavuzalp Solak
Yavuzalp Solak
EKErhan Kaya
Erhan Kaya
HDHasan Durmus
Hasan Durmus
HCHalil Canbolat
Halil Canbolat